Cite

HARVARD Citation

    Li, H. et al. (2020). Adverse cardiac events in the treatment of non-small cell lung cancer with programmed death-1and programmed death-ligand 1 inhibitors. Medicine. 99 (32), p. . [Online]. 
  
Back to record